Drugs for Alopecia, Androgenetic, 1 (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 69)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Ethanol |
Approved |
Phase 4 |
|
64-17-5 |
702 |
Synonyms:
(C6-C9)Alkyl alcohol
[CH2Me(OH)]
[OEtH]
02483_FLUKA
02851_FLUKA
02853_FLUKA
02854_FLUKA
02855_FLUKA
02856_FLUKA
02856_SIAL
02857_FLUKA
02857_SIAL
02858_FLUKA
02858_SIAL
02860_FLUKA
02865_FLUKA
02865_SIAL
02870_FLUKA
02870_SIAL
02875_FLUKA
02877_FLUKA
02878_FLUKA
02882_FLUKA
02882_SIAL
02883_FLUKA
02884_FLUKA
02890_FLUKA
02890_SIAL
02891_FLUKA
02891_SIAL
100C.NPA
121182-78-3
187380_ALDRICH
187380_SIAL
1-Hydroxyethane
24102_RIEDEL
24102_SIAL
24103_RIEDEL
24103_SIAL
24105_RIEDEL
24105_SIAL
24106_RIEDEL
24106_SIAL
24194_RIEDEL
24194_SIAL
245119_ALDRICH
245119_SIAL
270741_ALDRICH
270741_SIAL
277649_ALDRICH
277649_SIAL
2858_SIGMA
29221_FLUKA
32205_RIEDEL
32205_SIAL
32221_RIEDEL
32221_SIAL
32294_RIEDEL
32294_SIAL
34870_SIAL
34963_RIEDEL
39278_FLUKA
40210_ALDRICH
40210_RIEDEL
41322_FLUKA
458600_ALDRICH
458600_SIAL
459828_ALDRICH
459828_SIAL
459836_ALDRICH
459836_SIAL
459844_SIAL
48075_SUPELCO
493511_SIAL
493538_ALDRICH
493538_SIAL
493546_ALDRICH
493546_SIAL
64-17-5
676829_SIAL
68475-56-9
71076-86-3
71329-38-9
8000-16-6
8024-45-1
absolute alcohol
Absolute alcohol
Absolute Alcohol
Absolute ethanol
Absolute Ethanol
Absolute ethyl alcohol
AC1L19TW
AC1Q31MM
Aethanol
Aethanol [German]
Aethylalkohol
AHD 2000
AI3-01706
Alcare hand degermer
Alcare Hand Degermer
alcohol
Alcohol
Alcohol (ethyl)
Alcohol (USP)
Alcohol [USP]
ALCOHOL 5% IN D5-W
Alcohol anhydrous
Alcohol Anhydrous
Alcohol dehydrated
Alcohol denatured
alcohol etilico
Alcohol etilico
Alcohol etílico
Alcohol, absolute
Alcohol, Absolute
Alcohol, anhydrous
Alcohol, dehydrated
Alcohol, Dehydrated
Alcohol, denatured
Alcohol, diluted
Alcohol, Diluted
Alcohol, ethyl
Alcohol, grain
Alcohol, Grain
Alcohols
Alcohols, C1-3
Alcohols, C30
Alcohols, C6-9
Alcool ethylique
Alcool Ethylique
Alcool éthylique
Alcool etilico
Alcool Etilico
Algrain
Alkohol
Alkohol [German]
Alkoholu etylowego
Alkoholu Etylowego
Aminoethanol
Anhydrol
Anhydrol PM 4085
Anhydrous alcohol
Anhydrous ethanol
Äthanol
Äthylalkohol
Beta-Aminoethanol
Beta-Aminoethyl Alcohol
Beta-Ethanolamine
Beta-Hydroxyethylamine
bmse000297
C00469
C2H5OH
C2H6O
Caswell No. 426
Caswell No. 430
CCRIS 945
CDA 19
CDA 19-200
CHEBI:16236
|
CHEMBL545
CID702
Colamine
Cologne spirit
Cologne Spirit
Cologne spirits
D000431
D00068
DB00898
Dehydrated alcohol
Dehydrated ethanol
Dehydrated Ethanol
Denatured alcohol
Denatured Alcohol
Denatured Alcohol Cd-10
Denatured Alcohol Cd-5
Denatured Alcohol Cd-5a
Denatured Alcohol Sd-1
Denatured Alcohol Sd-13a
Denatured Alcohol Sd-17
Denatured Alcohol Sd-23a
Denatured Alcohol Sd-28
Denatured Alcohol Sd-30
Denatured Alcohol Sd-39b
Denatured Alcohol Sd-39c
Denatured Alcohol Sd-3a
Denatured Alcohol Sd-40m
Denatured ethanol
Denatured Ethanol
Desinfektol el
Desinfektol EL
Diluted alcohol
Distilled spirits
E2385_SIGMA
E7023_ALDRICH
E7023_SIAL
E7148_ALDRICH
E7148_SIAL
E7517_SIGMA
EINECS 200-578-6
EINECS 270-649-4
Envision Conditioner Pdd 9020
EOH
EOX
Esumiru WK 88
ETA
etanol
Etanol
Etanolo
Etanolo [Italian]
ethanol
éthanol
Ethanol (9CI)
Ethanol [JAN]
Ethanol 200 proof
Ethanol 200 Proof
Ethanol Absolute
Ethanol Absolute Bp
Ethanol Anhydrous
Ethanol Extra Pure
Ethanol solution
Ethanol Vapor
Ethanol, Silent Spirit
Ethanol, undenatured
Ethanolum anhydricum
Ethicap
Ethyl alc
ethyl alcohol
Ethyl alcohol
Ethyl Alcohol
Ethyl Alcohol & Water, 10%
Ethyl Alcohol & Water, 20%
Ethyl Alcohol & Water, 30%
Ethyl Alcohol & Water, 40%
Ethyl Alcohol & Water, 5%
Ethyl Alcohol & Water, 50%
Ethyl Alcohol & Water, 60%
Ethyl Alcohol & Water, 70%
Ethyl Alcohol & Water, 80%
Ethyl Alcohol & Water, 95%
Ethyl Alcohol & Water, 96%
Ethyl alcohol anhydrous
Ethyl Alcohol Anhydrous
Ethyl alcohol in alcoholic beverages
Ethyl alcohol usp
Ethyl Alcohol, Anhydrous
Ethyl Alcohol, Denatured
Ethyl hydrate
Ethyl Hydrate
Ethyl hydroxide
Ethyl Hydroxide
Ethylalcohol
Ethylalcohol [Dutch]
Ethylol
Ethylolamine
Ethyloxy Group
EtOH
Etylowy alkohol
FEMA No. 2419
FEMA Number 2419
Fermentation alcohol
Glycinol
grain alcohol
Grain alcohol
Hinetoless
HSDB 531
HSDB 82
Hydroxyethane
HYDROXYETHYL GROUP
I14-12648
IMS 99
Infinity pure
Infinity Pure
Jaysol
Jaysol S
LS-1539
LTBB002977
Lux
Methylated spirit
Methylated Spirit Mineralised
Methylcarbinol
Molasses alcohol
MolPort-001-785-844
NCGC00091458-01
nchem.651-comp3c
nchembio.552-comp10
nchembio.94-comp20
NCI-C03134
NSC 85228
NSC85228
Oxydimethylene Group
potato Alcohol
Potato alcohol
Punctilious ethyl alcohol
Pyro
QMHAIh@
Reagent Alcohol
Ru-Tuss Expectorant
SDA 3A
SDA 40-2
SDM No. 37
Sekundasprit
Silent spirit
Spirit
Spirits of wine
Spirits OF wine
spiritus vini
Spiritus vini
Spirt
SY Fresh M
Synasol
Tecsol
Tecsol C
Thanol
Thiofaco M-50
Undenatured ethanol
UNII-3K9958V90M
USAF EK-1597
WLN: Q2
|
|
2 |
|
Acetylcysteine |
Approved, Investigational |
Phase 4 |
|
616-91-1 |
12035 |
Synonyms:
(2R)-2-acetylamino-3-Sulfanylpropanoate
(2R)-2-acetylamino-3-sulfanylpropanoic acid
(2R)-2-acetylamino-3-Sulfanylpropanoic acid
(2R)-2-acetylamino-3-Sulphanylpropanoate
(2R)-2-acetylamino-3-Sulphanylpropanoic acid
(R)-2-acetylamino-3-Mercaptopropanoate
(R)-2-acetylamino-3-mercaptopropanoic acid
(R)-2-acetylamino-3-Mercaptopropanoic acid
(R)-Mercaptate
(R)-Mercaptic acid
(R)-mercapturic acid
(R)-Mercapturic acid
2-acetylamino-3-mercapto-Propionate
2-acetylamino-3-mercapto-Propionic acid
Ac pharma brand OF acetylcysteine
ACC
Acebraus
Acemuc
Acetabs
Acetadote
Acetilcisteina
Acetylcystein al
Acetylcystein atid
Acetylcystein heumann
Acetylcystein trom
Acetylcystein, mentopin
Acetylcysteine
Acetylcysteine ac-pharma brand
Acetylcysteine alcon brand
Acetylcysteine aluid brand
Acetylcysteine atid brand
Acetylcysteine azupharma brand
Acetylcysteine betapharm brand
Acetylcysteine bioiberica brand
Acetylcysteine bouchara brand
Acetylcysteine centrafarm brand
Acetylcysteine disphar brand
Acetylcysteine farmasan brand
Acetylcysteine fresenius brand
Acetylcysteine génévrier brand
Acétylcystéine GNR
Acetylcysteine GNR-pharma brand
Acetylcysteine guerbet brand
Acetylcysteine hermes brand
Acetylcysteine heumann brand
Acetylcysteine hydrochloride
Acetylcysteine inpharzam brand
Acetylcysteine intra brand
Acetylcysteine klinge brand
Acetylcysteine krewel brand
Acetylcysteine lichtenstein brand
Acetylcysteine lindopharm brand
Acetylcysteine merck brand
Acetylcysteine oberlin brand
Acetylcysteine pfleger brand
Acetylcysteine pharbita brand
Acetylcysteine roberts brand
Acetylcysteine sodium
Acetylcysteine temmler brand
Acetylcysteine teva brand
Acetylcysteine thiemann brand
Acetylcysteine trommsdorff brand
Acetylcysteine upsa brand
Acetylcysteine whitehall brand
Acetylcysteine zambon brand
Acetylcysteine zinc
Acetylcysteine zyma brand
Acetylcysteine, (D)-isomer
Acetylcysteine, (DL)-isomer
Acetylcysteine, monoammonium salt
Acetylcysteine, monosodium salt
Acetylcysteinum
Acetylin
Acetyst
Acid, mercapturic
Ac-pharma brand OF acetylcysteine
Airbron
Alcon brand OF acetylcysteine
Allen and hanburys brand OF acetylcysteine
Aluid brand OF acetylcysteine
Alveolex
Atid brand OF acetylcysteine
Azubronchin
Azupharma brand OF acetylcysteine
Betapharm brand OF acetylcysteine
Bioiberica brand OF acetylcysteine
Bisolvon nac
Boehringer ingelheim brand OF acetylcysteine
Bouchara brand OF acetylcysteine
Bristol myers squibb brand OF acetylcysteine
Bristol myers squibb brand OF acetylcysteine sodium salt
Bristol-myers squibb brand OF acetylcysteine
Bristol-myers squibb brand OF acetylcysteine sodium salt
Bromuc
broncho Fips
broncho-Fips
BronchoFips
Broncholysin
Broncoclar
Centrafarm brand OF acetylcysteine
Codotussyl
Cystamucil
|
dampo Mucopect
Dey brand OF acetylcysteine sodium salt
Disphar brand OF acetylcysteine
Durabronchal
Eurespiran
Exomuc
Fabrol
Farmasan brand OF acetylcysteine
Fluimicil infantil
Fluimucetin
Fluimucil
Flumucetin
Fluprowit
Frekatuss
Fresenius brand OF acetylcysteine
Genac
Génévrier brand OF acetylcysteine
GNR Pharma brand OF acetylcysteine
GNR-Pharma brand OF acetylcysteine
Guerbet brand OF acetylcysteine
Hermes brand OF acetylcysteine
Heumann brand OF acetylcysteine
Hoestil
Hustengetränk, optipect
Hydrochloride, acetylcysteine
Ilube
Inpharzam brand OF acetylcysteine
Intra brand OF acetylcysteine
Jenacystein
Jenapharm
Klinge brand OF acetylcysteine
Krewel brand OF acetylcysteine
L-a-acetamido-b-Mercaptopropionate
L-a-acetamido-b-Mercaptopropionic acid
L-acetylcysteine
L-Acetylcysteine
L-alpha-acetamido-beta-Mercaptopropionate
L-alpha-acetamido-beta-Mercaptopropionic acid
Lantamed
Larylin nac
Lichtenstein brand OF acetylcysteine
Lindocetyl
Lindopharm brand OF acetylcysteine
Lysox
L-α-acetamido-β-mercaptopropionate
L-α-acetamido-β-mercaptopropionic acid
m Pectil
Mentopin acetylcystein
Mercaptate
Mercaptic acid
Mercapturic acid
Merck brand OF acetylcysteine
Monoammonium salt acetylcysteine
Monosodium salt acetylcysteine
m-Pectil
MPectil
Muciteran
muco Sanigen
Mucolysin
Mucomyst
Mucopect, dampo
Mucosil
Mucosol
Mucosolvin
N Acetyl L cysteine
N Acetylcysteine
NAC
NAC al
NAC zambon
NAC, bisolvon
N-Acetyl-3-mercaptoalanine
N-acetylcysteine
N-Acetylcysteine
N-Acety-L-cysteine
N-acetyl-L-(+)-cysteine
N-Acetyl-L-(+)-cysteine
N-acetyl-L-cysteine
Oberlin brand OF acetylcysteine
Optipect hustengetränk
Parvolex
Pfleger brand OF acetylcysteine
Pharbita brand OF acetylcysteine
Produpharm lappe brand OF acetylcysteine
Roberts brand OF acetylcysteine
Roche nicholas brand OF acetylcysteine
Sanigen, muco
Siccoral
Siran
Sodium 2-acetamido-3-mercaptopropionate
Sodium, acetylcysteine
Solmucol
Temmler brand OF acetylcysteine
Teva brand OF acetylcysteine
Thiemann brand OF acetylcysteine
Trommsdorff brand OF acetylcysteine
UPSA brand OF acetylcysteine
Whitehall brand OF acetylcysteine
Zambon brand OF acetylcysteine
Zambon, nac
Zinc, acetylcysteine
Zyma brand OF acetylcysteine
|
|
3 |
|
Histamine |
Approved, Investigational |
Phase 4 |
|
51-45-6 |
774 |
Synonyms:
1H-Imidazole-4-ethanamine
2-(1H-Imidazol-4-yl)ethanamine
2-(1H-Imidazol-4-yl)ethylamine
2-(1H-Imidazol-5-yl)ethanamine
2-(1H-Imidazol-5-yl)ethylamine
2-(4-Imidazolyl)ethanamine
2-(4-imidazolyl)ethylamine
2-(4-Imidazolyl)ethylamine
2-Imidazol-4-ylethylamine
2-Imidazol-4-yl-ethylamine
4-(2-Aminoethyl)-1H-imidazole
4-(2-Aminoethyl)imidazole
4-imidazoleethylamine
4-Imidazoleethylamine
5-imidazoleethylamine
5-Imidazoleethylamine
beta-aminoethylglyoxaline
beta-Aminoethylglyoxaline
beta-aminoethylimidazole
|
beta-Aminoethylimidazole
beta-Aminothethylglyoxaline
beta-Imidazolyl-4-ethylamine
b-Imidazolyl-4-ethylamine
Ceplene
Dihydrochloride, histamine
Eramin
Ergamine
Ergotidine
Free histamine
Histamine dihydrochloride
Histamine hydrochloride
HSM
Hydrochloride, histamine
L-Histamin base
L-Histamine
Peremin
Theramine
|
|
4 |
|
Cetirizine |
Approved |
Phase 4 |
|
83881-51-0 |
2678 |
Synonyms:
(2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)acetic acid
(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid
(2-{4-[(4-Chloro-phenyl)-phenyl-methyl]-piperazin-1-yl}-ethoxy)-acetic acid
[(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethyl)oxy]acetic acid
2-(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid
2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid
83881-51-0
83881-52-1 (di-hydrochloride)
AC1L1E7T
AC1Q768B
AC-5545
AKOS003589059
Alerlisin
Aliud brand OF cetirizine dihydrochloride
Alpharma brand OF cetirizine dihydrochloride
AWD.pharma brand OF cetirizine dihydrochloride
Azupharma brand OF cetirizine dihydrochloride
Basics brand OF cetirizine dihydrochloride
Benaday
BPBio1_000469
BRD-A42571354-300-05-4
BSPBio_000425
BSPBio_002302
C07778
C21H25ClN2O3
Cetalerg
Ceterifug
Ceti tad
Cetiderm
Cetiderm (TN)
Cetidura
Cetil von CT
CetiLich
Ceti-puren
Cetirigamma
Cetirizin
Cetirizin al
Cetirizin azu
Cetirizin basics
Cetirizina
Cetirizina [Spanish]
cetirizine
Cetirizine
Cetirizine (INN)
Cetirizine [INN:BAN]
Cetirizine dihydrochloride
Cetirizine hydrochloride
Cetirizinum
Cetirizinum [Latin]
Cetirlan
Cetrizine Hcl
Cetryn
CHEBI:3561
CHEMBL1000
CID2678
CPD001453715
|
CT-Arzneimittel brand OF cetirizine dihydrochloride
D07662
DB00341
Dermapharm brand OF cetirizine dihydrochloride
Dihydrochloride, cetirizine
glaxo Wellcome brand OF cetirizine dihydrochloride
Hitrizin Film Tablet
HMS1539O07
Humex
I06-0454
Krewel brand OF cetirizine dihydrochloride
L000655
Lacer brand OF cetirizine dihydrochloride
Lichtenstein brand OF cetirizine dihydrochloride
LS-11409
Menarini brand OF cetirizine dihydrochloride
Merck dura brand OF cetirizine dihydrochloride
MLS002222268
MolPort-002-506-309
NCGC00167781-01
NCGC00167781-02
NCGC00167781-03
NCGC00167781-04
nchembio714-comp3
P-071
Pfizer brand OF cetirizine dihydrochloride
Pfizer consumer healthcare brand OF cetirizine dihydrochloride
Prestwick0_000503
Prestwick1_000503
Prestwick2_000503
Prestwick3_000503
Reactine
Rodleben brand OF cetirizine
SAM002589989
Sanofi synthelabo brand OF cetirizine dihydrochloride
Setir
SMR000145214
SPBio_002346
STK711108
STOCK2S-03020
TAD brand OF cetirizine dihydrochloride
TimTec1_002075
UCB brand OF cetirizine dihydrochloride
UCB pharma brand OF cetirizine dihydrochloride
UNII-YO7261ME24
United drug brand OF cetirizine dihydrochloride
Virlix
Voltric
Wolff brand OF cetirizine dihydrochloride
Wörwag brand OF cetirizine dihydrochloride
Zetir
Ziptek
Zirtek
Zyrlex
Zyrtec
|
|
5 |
|
Cysteine |
Approved, Nutraceutical |
Phase 4 |
|
52-90-4 |
5862 |
Synonyms:
(+)-2-amino-3-Mercaptopropionic acid
(2R)-2-amino-3-Mercaptopropanoate
(2R)-2-amino-3-mercaptopropanoic acid
(2R)-2-amino-3-Mercaptopropanoic acid
(2R)-2-amino-3-Sulfanylpropanoate
(2R)-2-amino-3-sulfanylpropanoic acid
(2R)-2-amino-3-Sulfanylpropanoic acid
(2R)-2-amino-3-Sulphanylpropanoate
(2R)-2-amino-3-Sulphanylpropanoic acid
(R)-(+)-Cysteine
(R)-2-amino-3-mercapto-Propanoate
(R)-2-amino-3-Mercaptopropanoate
(R)-2-amino-3-mercapto-Propanoic acid
(R)-2-amino-3-Mercaptopropanoic acid
(R)-2-Amino-3-mercaptopropanoic acid
(R)-Cysteine
2-amino-3-Mercaptopropanoate
2-amino-3-Mercaptopropanoic acid
2-amino-3-Mercaptopropionate
2-amino-3-Mercaptopropionic acid
3-mercapto-L-Alanine
Acetylcysteine
alpha-amino-beta-Thiolpropionic acid
beta-Mercaptoalanine
b-Mercaptoalanine
C
Carbocysteine
Cisteina
|
Cisteinum
Cys
Cystein
Cysteine
CYSTEINE
Cysteine hydrochloride
Cysteinum
e 920
e920
e-920
Free Cysteine
FREE cysteine
Half cystine
Half-cystine
L Cysteine
L-(+)-Cysteine
L-2-amino-3-Mercaptopropanoate
L-2-amino-3-Mercaptopropanoic acid
L-2-amino-3-Mercaptopropionate
L-2-amino-3-Mercaptopropionic acid
L-2-Amino-3-mercaptopropionic acid
L-Cys
L-Cystein
L-Zystein
Polycysteine
Thioserine
Zinc cysteinate
|
|
6 |
|
Anti-Infective Agents |
|
Phase 4 |
|
|
|
7 |
|
Anti-Infective Agents, Local |
|
Phase 4 |
|
|
|
8 |
|
Fenugreek |
|
Phase 4 |
|
|
|
9 |
|
Fenugreek seed meal |
|
Phase 4 |
|
|
|
10 |
|
N-monoacetylcystine |
|
Phase 4 |
|
|
|
11 |
|
Histamine Antagonists |
|
Phase 4 |
|
|
|
12 |
|
Histamine H1 Antagonists, Non-Sedating |
|
Phase 4 |
|
|
|
13 |
|
Anti-Allergic Agents |
|
Phase 4 |
|
|
|
14 |
|
Histamine H1 Antagonists |
|
Phase 4 |
|
|
|
15 |
|
Histamine Phosphate |
|
Phase 4 |
|
51-74-1 |
65513 |
Synonyms:
1H-Imidazole-4-ethanamine, phosphate (1:2)
2-Imidazol-4-ylethylamine orthophosphoric acid (1:2)
4-(2-Aminoethyl)imidazole bis(dihydrogen phosphate)
4-(2-Aminoethyl)imidazole di-acid phosphate
4-2(2-Aminoethyl)Imidazole-Di-Acid Phosphate
51-74-1
53623-99-7
74-56-6
AC1L23E4
CID65513
D04445
DB00667
EINECS 200-118-4
|
H0147
Histamine acid phosphate
Histamine biphosphate
Histamine dihydrogen phosphate
Histamine diphosphate
Histamine phosphate (1:2)
Histamine phosphate (TN)
Histamine phosphate (USP)
Histamine phosphate [USP]
Histamine positive
LS-78569
UNII-QWB37T4WZZ
|
|
16 |
|
Neurotransmitter Agents |
|
Phase 4 |
|
|
|
17 |
|
Dutasteride |
Approved, Investigational |
Phase 3 |
|
164656-23-9 |
152945 6918296 |
Synonyms:
(1S,3aS,3bS,5aR,9aR,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-[2,5-bis(trifluoromethyl)phenyl]-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
(5.alpha.,17.beta.)-N-{2,5 bis(trifluoromethyl)phenyl}-3-oxo-4-azaandrost-1-ene-17-carboxamide
(5a,17b)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide
(5alpha,17beta)-N-(2,5-Bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide
(5α,17β)-N-(2,5-bis(trifluoromethyl)phenyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide
164656-23-9
17beta-N-(2,5-Bis(trifluoromethyl))phenyl-carbamoyl-4-aza-5alpha-androst-1-en-3-one
745, GG
a,a,a,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5a-androst-1-ene-17b-carboxy-2',5'-xylidide
AC1L49EM
AC1OCF98
alpha,alpha,alpha,alpha',alpha',alpha'-Hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide
alpha,alpha,alpha,Alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxy-2',5'-xylidide
Avodart
Avodart (TN)
Avodart, Dutasteride
Avolve
Bio-0167
C27H30F6N2O2
CHEBI:132773
CHEMBL1200969
CHEMBL283245
CID152945
CID6918296
|
CID9914880
D03820
DB01126
Duagen
Dutasterida
Dutasteride
Dutasteride (JAN/USAN/INN)
Dutasteride [USAN]
FT-0080365
GG 745
GG-745
GI 198745
GI-198745
GI-198745X
LS-173584
MolPort-003-666-660
MolPort-003-847-041
N-[2,5-bis(trifluoromethyl)phenyl]-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide
NSC740477
S1202_Selleck
UNII-O0J6XJN02I
ZINC03932831
α,α,α,alpha',alpha',alpha'-hexafluoro-3-oxo-4-aza-5α-androst-1-ene-17β-carboxy-2',5'-xylidide
α,α,α,α',α',α'-hexafluoro-3-oxo-4-aza-5α-androst-1-ene-17β-carboxy-2',5'-xylidide
|
|
18 |
|
Zinc |
Approved, Investigational |
Phase 1, Phase 2 |
|
7440-66-6 |
32051 |
Synonyms:
alpha D Mannosidase
alpha D Mannoside mannohydrolase
alpha Mannosidase
alpha Mannosidase b
alpha-D-Mannosidase
alpha-D-Mannoside mannohydrolase
alpha-Mannosidase
alpha-Mannosidase, lysosomal
alpha-Mannosidase, neutral
Dietary zinc
LAMAN
Lysosomal alpha mannosidase
Lysosomal alpha-mannosidase
Mannohydrolase, alpha-D-mannoside
|
Mannosidase b, alpha
Neutral alpha mannosidase
Neutral alpha-mannosidase
Topostin b
Zinc cation
ZINC ion
Zinc, chelated
Zinc, elemental
Zinc, ion (ZN2+)
Zincum metallicum
Zn
ZN(2+)
ZN(II)
ZN2+
|
|
19 |
|
Nitric Oxide |
Approved |
Phase 1, Phase 2 |
|
10102-43-9 |
145068 |
Synonyms:
(.)NO
(no)(.)
(NO)(.)
[no]
[NO]
10102-43-9
14332-28-6
295566_ALDRICH
51005-20-0
51005-21-1
53851-19-7
90452-29-2
AC1L1ADQ
AC1L3QHF
AC1Q6QZ0
AR-1K7463
Bioxyde d'azote
Bioxyde d'azote [French]
C00533
CCRIS 4319
CHEMBL1200689
CHEMBL1234765
CID145068
CID945
D00074
D009569
DB00435
EDRF
EINECS 233-271-0
Endogenous nitrate vasodilator
Endogenous Nitrate Vasodilator
Endothelium-derived nitric oxide
Endothelium-Derived Nitric Oxide
endothelium-derived relaxing factor
Endothelium-derived relaxing factor
HNO
HSDB 1246
INOmax
INOmax (TN)
LS-192158
LS-7547
MolPort-003-929-452
Mononitrogen monoxide
Monoxide, mononitrogen
Monoxide, Mononitrogen
Monoxide, nitrogen
Monoxide, Nitrogen
monoxido de nitrogeno
monoxido De nitrogeno
Monóxido de nitrógeno
monoxyde d'azote
Monoxyde d'azote
Nitrate vasodilator, endogenous
Nitrate Vasodilator, Endogenous
|
nitric oxide
Nitric oxide
Nitric oxide (JAN)
Nitric oxide 10% by volume or more
Nitric oxide trimer
Nitric oxide, compressed [UN1660] [Poison gas]
Nitric oxide, compressed [UN1660] [Poison gas]
Nitric oxide, endothelium derived
Nitric Oxide, Endothelium Derived
Nitric oxide, endothelium-derived
Nitric Oxide, Endothelium-Derived
NITRIC-OXIDE
nitrogen monooxide
Nitrogen monooxide
nitrogen monoxide
Nitrogen monoxide
Nitrogen oxide
Nitrogen oxide (NO)
Nitrogen protoxide
nitrosyl
Nitrosyl
Nitrosyl hydride
Nitrosyl hydride ((NO)H)
Nitrosyl radical
Nitroxide radical
Nitroxyl
NO
no(.)
NO(.)
OHM 11771
Oxide, nitric
Oxide, Nitric
oxido de nitrogeno(II)
oxido De nitrogeno(II)
óxido de nitrógeno(II)
oxido nitrico
oxido Nitrico
óxido nítrico
oxidonitrogen(.)
oxoazanyl
oxyde azotique
Oxyde azotique
Oxyde nitrique
Oxyde nitrique [French]
RCRA waste no. P076
Stickmonoxyd
Stickmonoxyd [German]
Stickstoff(II)-oxid
Stickstoffmonoxid
UN 1660
UN1660
UNII-31C4KY9ESH
Vasodilator, endogenous nitrate
Vasodilator, Endogenous Nitrate
|
|
20 |
|
Acetylcholine |
Approved, Investigational |
Phase 2 |
|
51-84-3 |
187 |
Synonyms:
2-(Acetyloxy)-N,N,N-trimethylethanaminium
Acetilcolina cusi
Acetyl choline ion
Acetylcholine bromide
Acetylcholine cation
acetylcholine chloride
Acetylcholine chloride
Acetylcholine fluoride
Acetylcholine hydroxide
Acetylcholine iodide
Acetylcholine L tartrate
Acetylcholine L-tartrate
Acetylcholine perchlorate
Acetylcholine picrate
Acetylcholine picrate (1:1)
Acetylcholine sulfate (1:1)
Acetylcholinium: acetyl-choline
ACh
Alcon brand OF acetylcholine chloride
|
Azetylcholin
Bournonville brand OF acetylcholine chloride
Bromide, acetylcholine
Bromoacetylcholine
Chloroacetylcholine
Choline acetate
Choline acetate (ester)
Choline acetic acid
Ciba vision brand OF acetylcholine chloride
Cusi, acetilcolina
Fluoride, acetylcholine
Hydroxide, acetylcholine
Iodide, acetylcholine
Iolab brand OF acetylcholine chloride
L-Tartrate, acetylcholine
Miochol
O-Acetylcholine
Perchlorate, acetylcholine
|
|
21 |
|
Bimatoprost |
Approved, Investigational |
Phase 2 |
|
155206-00-1 |
5311027 |
Synonyms:
(5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide
(Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E,3S)-3-hydroxy-5-phenylpent-1-enyl]cyclopentyl]-N-ethylhept-5-enamide
155206-00-1
15M
267244-98-4
5-Heptenamide,7-((1R,2R,3R,5S)-3,5-dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ehtyl-,(5Z)
AC1NSJUW
AGN 192024
AGN-192024
Bimataprost [USAN:INN:BAN]
Bimatoprost
Bimatoprost (JAN/USAN/INN)
Bimatoprost [USAN:INN:BAN]
bimatoprostum
Bimatoprostum
|
CHEBI:39562
CHEBI:51230
CHEMBL1200963
CID5311027
D02724
DB00905
DB06863
I06-1275
I06-1277
Latisse
LS-181817
Lumigan
Lumigan (TN)
NCGC00181745-01
UNII-QXS94885MZ
ZINC04474405
|
|
22 |
|
Valproic acid |
Approved, Investigational |
Phase 2 |
|
99-66-1 |
3121 |
Synonyms:
(N-C3H7)2chcooh
(S)-2-Propyl-4-pentanoate
(S)-2-Propyl-4-pentanoic acid
2 PP (base)
2 Propylpentanoic acid
2-N-Propyl-N-valerate
2-n-propyl-n-valeric acid
2-n-Propyl-n-valeric acid
2-N-Propyl-N-valeric acid
2-Propylpentanoate
2-PROPYL-pentanoate
2-propyl-pentanoic acid
2-Propylpentanoic acid
2-Propylpentanoic Acid
2-PROPYL-pentanoIC ACID
2-Propylvalerate
2-propylvaleric acid
2-Propylvaleric acid
2-Propylvaleric Acid
4-Heptanecarboxylate
4-heptanecarboxylic acid
4-Heptanecarboxylic acid
76584-70-8 (hydrochloride salt (2:1))
99-66-1
Abbott 44090
AC1L1F7T
AC1Q2ULA
Acetate, dipropyl
Acid, propylisopropylacetic
Acid, valproic
Acide valproique
acide valproïque
Acide valproique [INN-French]
acido Valproico
Acido valproico
ácido valproico
Acido valproico [INN-Spanish]
acidum valproicum
Acidum valproicum
Acidum valproicum [INN-Latin]
AI3-10500
Alti-valproic
Alti-Valproic
apo-Divalproex
apo-Valproic
apo-Valproic syrup
Avugane
Baceca
BIDD:GT0858
BRN 1750447
C07185
Calcium valproate
Calcium, valproate
CHEBI:39867
CHEMBL109
CID3121
Convulex
Convulsofin
CPD000499581
D00399
DB00313
Delepsine
Depacon
Depakene
Depakene (TN)
Depakin
Depakin chrono
Depakine
Depakine chrono
Depakote
Depakote (TM)
Deproic
Di-N-propylacetate
di-n-propylacetic acid
Di-n-propylacetic acid
Di-N-propylacetic acid
Di-n-propylessigsaeure
Di-N-propylessigsaeure
Di-n-propylessigsaure
Di-N-propylessigsaure
Di-n-propylessigsäure
Di-n-propylessigsaure [German]
Dipropyl acetate
Dipropyl Acetate
Dipropylacetate
Dipropylacetic acid
Divalproex
Divalproex sodium
DivK1c_000273
DOM-divalproex
Dom-valproate
Dom-Valproic
DOM-valproic
Dom-valproic acid
DOM-valproic acid e.c.
Dom-valproic acid syrup
DPA
EINECS 202-777-3
Epiject i.v.
Epilex
Epilim
Epival
Epival er
Ergenyl
G2M-777
Gen-divalproex
HMS2089J06
HSDB 3582
I04-0211
InChI=1/C8H16O2/c1-3-5-7(6-4-2)8(9)10/h7H,3-6H2,1-2H3,(H,9,10)
KBio1_000273
KBio2_001001
KBio2_002277
KBio2_003569
|
KBio2_004845
KBio2_006137
KBio2_007413
KBio3_002626
KBio3_002757
KBioGR_000871
KBioGR_002277
KBioSS_001001
KBioSS_002278
Kyselina 2-propylvalerova
Kyselina 2-propylvalerova [Czech]
LS-161170
LS-2068
Magnesium valproate
Med valproic
Med Valproic
MLS001076682
MLS001335927
MLS001335928
MLS002415770
MolPort-001-791-895
Mylproin
Myproate
Myproic acid
Myproic Acid
NCGC00091149-01
NCGC00091149-02
NCGC00091149-03
NCGC00091149-04
nchembio.79-comp4
nchembio815-comp21
n-Dipropylacetic acid
N-Dipropylacetic acid
n-DPA
N-DPA
NINDS_000273
novo-Divalproex
novo-Valproic
Novo-Valproic
novo-Valproic - ecc
novo-Valproic soft gel cap
NSC 93819
NSC93819
Nu-valproic
Nu-Valproic
P0823
P6273_SIGMA
PEAC
Penta-valproic
Penta-Valproic
PHL-Valproate
PHL-Valproic acid
PHL-Valproic acid e.c.
PMS-Divalproex
PMS-Valproate
PMS-Valproic acid
PMS-Valproic Acid
PMS-Valproic acid e.c.
Propylisopropylacetic acid
Propylvaleric acid
ratio-Valproic - ecc
S(-)-4-En-valproate
S(-)-4-En-valproic acid
S-2-N-Propyl-4-pentenoate
S-2-N-Propyl-4-pentenoic acid
SAM002564230
Sandoz valproic
Savicol
SBB065764
Semisodium valproate
Semisodium Valproate
SMR000499581
Sodium hydrogen divalproate
Sodium valproate
Sodium, divalproex
Sodium, valproate
SPBio_000912
Spectrum_000521
Spectrum2_000946
Spectrum3_001733
Spectrum4_000376
Sprinkle
Stavzor
UNII-614OI1Z5WI
Valcote
Valparin
valproate
Valproate
Valproate calcium
Valproate semisodique [French]
Valproate semisodium
Valproate sodium
Valproate, calcium
Valproate, magnesium
Valproate, semisodium
Valproate, sodium
Valproato semisodico [Spanish]
Valproatum seminatricum [Latin]
valproic acid
Valproic acid
VALPROIC ACID
Valproic acid (USP)
Valproic acid [USAN:INN:BAN]
Valproic acid usp
Valproic acid USP
Valproic acid USP24
Valproic acid, sodium salt (2:1)
Valproic Acid, Sodium Salt (2:1)
Valproinsaeure
Valproinsäure
VPA
Vupral
WLN: QVY3 & 3
|
|
23 |
|
Vitamin C |
Approved, Nutraceutical |
Phase 1, Phase 2 |
|
50-81-7 |
5785 54670067 |
Synonyms:
(+)-Ascorbate
(+)-Ascorbic acid
(+)-Sodium L-ascorbate
(2R)-2-[(1S)-1,2-dihydroxyethyl]-4,5-dihydroxyfuran-3-one
(2R)-2-[(1S)-1,2-Dihydroxyethyl]-4,5-dihydroxy-furan-3-one
(5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyfuran-2(5H)-one
129940-97-2
134-03-2 (monosodium salt)
14536-17-5
154170-90-8
2-(1,2-Dihydroxyethyl)-4,5-dihydroxyfuran-3-one
255564_SIAL
259133-78-3
30208-61-8
33034_RIEDEL
33034_SIAL
3-keto-L-Gulofuranolactone
3-Keto-L-gulofuranolactone
3-oxo-L-Gulofuranolactone
3-Oxo-L-gulofuranolactone
3-Oxo-L-gulofuranolactone (enol form)
47863_SUPELCO
47A605F0-4187-47A8-B0CE-F9E7DA1B0076
50-81-7
50976-75-5
56172-55-5
56533-05-2
57304-74-2
57606-40-3
623158-95-2
6730-29-6
882690-91-7
884381-69-5
885512-24-3
88845-26-5
89924-69-6
95209_FLUKA
95209_SIGMA
95210_FLUKA
95210_SIAL
95212_FLUKA
A0278_SIGMA
A0537
A2174_SIGMA
A2218_SIGMA
A2343_SIGMA
A4403_SIGMA
A4544_SIGMA
A5960_SIGMA
A7506_SIGMA
A92902_ALDRICH
A92902_SIAL
AA
AB00376923
AB1002440
AC1L1L4T
AC1Q77S6
Acid Ascorbic
Acid, ascorbic
Acid, L-ascorbic
acide ascorbique
Acide ascorbique
Acide ascorbique [INN-French]
acido Ascorbico
Acido ascorbico
ácido ascórbico
Acido ascorbico [INN-Spanish]
Acidum ascorbicum
Acidum ascorbicum [INN-Latin]
acidum ascorbinicum
Acidum ascorbinicum
Adenex
Allercorb
Ambap36431-82-0
antiscorbic vita min
Antiscorbic vitamin
Antiscorbic Vitamin
Antiscorbutic factor
Antiscorbutic vitamin
Antiscorbutic Vitamin
AR-1J3435
arco-Cee
Arco-cee
Arco-Cee
Ascoltin
Ascoltin (TN)
Ascorb
ascor-b.i.d
Ascor-b.i.d.
Ascor-B.I.D.
Ascorbajen
ascorbate
Ascorbate
Ascorbate, ferrous
Ascorbate, magnesium
Ascorbate, sodium
ascorbic acid
Ascorbic acid
Ascorbic Acid
Ascorbic acid (JP15/USP/INN)
Ascorbic acid [BAN:INN:JAN]
Ascorbic acid [INN:BAN:JAN]
Ascorbic acid, monosodium salt
Ascorbic Acid, Monosodium Salt
Ascorbicab
Ascorbicap
Ascorbicap (TN)
Ascorbicin
Ascorbin
Ascorbinsaeure
Ascorbinsäure
Ascorbutina
Ascorbyl radical
Ascorin
Ascorteal
Ascorvit
bmse000182
BPBio1_000363
BSPBio_000329
C00072
C6H8O6
Cantan
Cantaxin
Caswell No. 061B
Catavin C
CCRIS 57
Ce lent
Ce Lent
Cebicure
Cebid
Cebion
Cebione
Cecon
cee-caps td
Cee-caps TD
Cee-Caps Td
Cee-Caps TD
Cee-vite
Cee-Vite
Cegiolan
Ceglion
Ceklin
Celaskon
Celin
Cell C
Cemagyl
Ce-mi-lin
Ce-Mi-Lin
Cemill
Cenetone
Cenolate
Cereon
Cergona
Cescorbat
Cetamid
Cetane
Cetane-caps TC
Cetane-Caps Tc
Cetane-Caps TC
Cetane-caps TD
Cetane-Caps Td
Cetane-Caps TD
Cetebe
Cetemican
Cevalin
|
Cevatine
Cevex
cevibid
Cevi-bid
Cevi-Bid
Cevimin
Ce-vi-sol
CE-VI-Sol
Cevital
Cevitamate
Cevitamic acid
Cevitamic Acid
Cevitamin
Cevitan
Cevitex
Cewin
CHEBI:29073
CHEMBL196
Chewcee
Ciamin
CID5785
Cipca
Citriscorb
Citrovit
C-Level
C-Long
Colascor
component of Cortalex
component of E and C-Level
component of Endoglobin Forte
component of Ferancee
Concemin
Cortalex
C-Quin
C-Span
C-Vimin
D00018
Davitamon C
DB00126
Di-L-ascorbate, magnesium
Dora-C-500
Duoscorb
e 300
e300
e-300
EINECS 200-066-2
FEMA No. 2109
Ferancee
Ferrous ascorbate
gamma-Lactone L-threo-hex-2-enonate
gamma-Lactone L-threo-hex-2-enonic acid
Hicee
HiCee
HSDB 818
Hybrin
ido-C
IDO-C
Iron(II) ascorbate
Iron-ascorbic acid complexes
Juvamine
Kangbingfeng
Kyselina askorbova
Kyselina Askorbova
Kyselina askorbova [Czech]
L Ascorbic acid
L(+)-Ascorbate
L-(+)-Ascorbate
L-(+)-ascorbic acid
L(+)-Ascorbic acid
L-(+)-Ascorbic acid
L-(+)-Ascorbic Acid
L-3-ketothreohexuronic acid
L-3-Ketothreohexuronic acid lactone
Laroscorbine
L-ascorbate
L-Ascorbate
l-ascorbic acid
L-Ascorbic acid
L-Ascorbic Acid
L-Ascorbic acid, free radical form
Lemascorb
Liqui-cee
Liqui-Cee
L-Lyxoascorbate
L-Lyxoascorbic acid
L-Lyxoascorbic Acid
LS-145
L-threo-ascorbic acid
L-threo-Ascorbic acid
L-Threoascorbic acid
l-threo-hex-1-eofuranos-3-ulose
L-threo-Hex-2-enonic acid, gamma-lactone
L-threo-hex-2-enono-1,4-lactone
L-Xyloascorbate
L-Xyloascorbic acid
L-Xyloascorbic Acid
Magnesium ascorbate
Magnesium ascorbicum
Magnesium Ascorbicum
Magnesium di L ascorbate
Magnesium di-L-ascorbate
Magnorbin
Meri-c
Meri-C
MLS002153776
MolPort-001-792-501
Monodehydroascorbic acid
Natrascorb
Natrascorb injectable
NCGC00091517-01
NCGC00091517-02
NCGC00164357-01
nchembio.174-comp5
nchembio.89-comp1
nchembio.92-comp2
nchembio821-comp9
NCI-C54808
NSC 33832
Oral Vitamin C
Planavit C
Prestwick3_000325
Proscorbin
Redoxon
Ribena
Ronotec 100
Rontex 100
roscorbi c
Roscorbic
Rovimix C
Scorbacid
Scorbu C
Scorbu-C
Secorbate
Semidehydroascorbate
SMR001233160
Sodascorbate
Sodium ascorbate
Sodium Ascorbate (Ascorbic Acid)
Stuartinic
Suncoat VC 40
Sunkist
Testascorbic
Tolfrinic
UNII-PQ6CK8PD0R
VASC
Vicelat
Vicin
Vicomin C
Viforcit
Viscorin
Viscorin 100m
Vitace
Vitacee
Vitacimin
Vitacin
vitamin C
Vitamin C
Vitamin- C
Vitamin-?C
Vitamina C
Vitamisin
Vitascorbol
W210901_ALDRICH
Xitix
|
|
24 |
|
Maleic acid |
Experimental, Investigational |
Phase 1, Phase 2 |
|
110-17-8, 110-16-7 |
444972 |
Synonyms:
(2E)-2-Butenedioate
(2E)-2-butenedioic acid
(2E)-2-Butenedioic acid
(2E)-But-2-enedioate
(2E)-but-2-enedioic acid
(2E)-But-2-enedioic acid
(e)-2-Butenedioate
(e)-2-Butenedioic acid
(E)-2-butenedioic acid
(E)-2-Butenedioic acid
(E)-but-2-enedioic acid
03761_FLUKA
1,2-Ethylenedicarboxylic acid, (E)
110-17-8
2-(e)-Butenedioate
2-(e)-Butenedioic acid
2-(E)-Butenedioic acid
240745_ALDRICH
240745_SIAL
26B3632D-E93F-4655-90B0-3C17855294BA
2-Butenedioic acid
2-Butenedioic acid (2E)- (9CI)
4-02-00-02202 (Beilstein Handbook Reference)
623158-97-4
AB1002616
AC1L9H76
AC1Q5T7Y
AC1Q71EM
Acidum fumaricum
AI3-24236
AKOS000118896
Allomaleate
Allomaleic acid
Allomalenic acid
ammonium fumarate
Ammonium fumarate
AR-1D9767
bmse000083
Boletate
Boletic acid
BRN 0605763
But-2-enedioic acid
Butenedioic acid
C00122
C4H4O4
Caswell No. 465E
CCRIS 1039
CHEBI:18012
CHEBI:22958
CHEMBL503160
CID444972
D02308
DB04299
e297
E-2-Butenedioic acid
EINECS 203-743-0
|
EPA Pesticide Chemical Code 051201
F0067
F8509_SIGMA
FC 33
FC 33 (acid)
FEMA No. 2488
FEMA Number 2488
fum
fumarate
Fumarate
fumarate, 10
fumaric acid
Fumaric acid (8CI)
Fumaric acid (NF)
Fumaricum acidum
Fumarsaeure
Fumarsäure
Furamag
HSDB 710
I04-1070
Kyselina fumarova
Kyselina fumarova [Czech]
Lichenate
Lichenic acid
Lichenic acid (VAN)
LMFA01170106
LS-500
Magnesium fumarate
MLS002454406
MolPort-001-780-031
MolPort-004-288-293
NCGC00091192-01
nchembio.186-comp71
nchembio.2007.47-comp1
NSC2752
NSC-2752
OR17920
S04-0167
SMR000112117
Sodium fumarate
trans-1,2-Ethylenedicarboxylate
trans-1,2-ethylenedicarboxylic acid
trans-1,2-Ethylenedicarboxylic acid
trans-2-Butenedioate
trans-2-Butenedioic acid
trans-But-2-enedioate
trans-but-2-enedioic acid
trans-But-2-enedioic acid
trans-Butenedioate
trans-Butenedioic acid
Tumaric acid
U-1149
UNII-88XHZ13131
USAF EK-P-583
W248800_ALDRICH
WLN: QV1U1VQ-T
|
|
25 |
|
Trace Elements |
|
Phase 1, Phase 2 |
|
|
|
26 |
|
Nutrients |
|
Phase 1, Phase 2 |
|
|
|
27 |
|
Micronutrients |
|
Phase 1, Phase 2 |
|
|
|
28 |
|
Adjuvants, Immunologic |
|
Phase 2 |
|
|
|
29 |
|
Protective Agents |
|
Phase 2 |
|
|
|
30 |
|
Radiation-Protective Agents |
|
Phase 2 |
|
|
|
31 |
|
Antiviral Agents |
|
Phase 2 |
|
|
|
32 |
|
Ammonium trichloro(dioxoethylene-O,O'-)tellurate |
|
Phase 2 |
|
|
|
33 |
|
Chelating Agents |
|
Phase 1, Phase 2 |
|
|
|
34 |
|
Zinc Supplement |
|
Phase 1, Phase 2 |
|
|
|
35 |
|
Respiratory System Agents |
|
Phase 1, Phase 2 |
|
|
|
36 |
|
Antioxidants |
|
Phase 1, Phase 2 |
|
|
|
37 |
|
Anti-Asthmatic Agents |
|
Phase 1, Phase 2 |
|
|
|
38 |
|
Endothelium-Dependent Relaxing Factors |
|
Phase 1, Phase 2 |
|
|
|
39 |
|
Bronchodilator Agents |
|
Phase 1, Phase 2 |
|
|
|
40 |
|
abobotulinumtoxinA |
|
Phase 2 |
|
|
|
41 |
|
Cholinergic Agents |
|
Phase 2 |
|
|
|
42 |
|
Botulinum Toxins |
|
Phase 2 |
|
|
|
43 |
|
Botulinum Toxins, Type A |
|
Phase 2 |
|
|
|
44 |
|
protease inhibitors |
|
Phase 2 |
|
|
|
Synonyms:
|
45 |
|
HIV Protease Inhibitors |
|
Phase 2 |
|
|
|
46 |
|
Proteasome Inhibitors |
|
Phase 2 |
|
|
|
47 |
|
Androgens |
|
Phase 2 |
|
|
|
48 |
|
Ophthalmic Solutions |
|
Phase 2 |
|
|
|
49 |
|
Psychotropic Drugs |
|
Phase 2 |
|
|
|
50 |
|
Anticonvulsants |
|
Phase 2 |
|
|
|
Interventional clinical trials:
(show top 50)
(show all 133)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Evaluating the Efficacy of Different Platelet Rich Plasma (PRP) Treatment Regimens in the Management of Androgenetic Alopecia: an Investigator-initiated, Single-center, Single-blinded, Prospective, Randomized Clinical Trial |
Unknown status |
NCT02999737 |
Phase 4 |
|
2 |
Minoxidil in Treatment of Androgenetic Alopecia |
Completed |
NCT04090801 |
Phase 4 |
Topical minoxidil 5% in 90% ethanol and 5% propylene glycol;Topical minoxidil 5% in pure ethanol alone |
3 |
Efficacy and Safety of Furocyst in Patients With Poly Cystic Ovary Syndrome |
Completed |
NCT02789488 |
Phase 4 |
|
4 |
Efficacy and Tolerability of N-Acetyl- Cysteine for Treatment of The Early-onset Androgenetic Alopecia in Men |
Recruiting |
NCT04209803 |
Phase 4 |
Minoxidil 5% topically and oral NAC 600 mg |
5 |
the Effect of Adipose Derived Stem Cells Combined With Platelet Rich Plasma Versus Platelet Rich Plasma Alone on Follicular Unit Extraction Hair Transplantion in Male Androgenic Alopecia: Clinical Trial |
Recruiting |
NCT03388840 |
Phase 4 |
|
6 |
Topical Cetirizine Gel Versus Minoxidil 5% Gel in Treatment of Androgenetic Alopecia |
Not yet recruiting |
NCT04293822 |
Phase 4 |
Cetirizine;Minoxidil |
7 |
The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia |
Withdrawn |
NCT02483195 |
Phase 4 |
5% Minoxidil;200mg Spironolactone;5mg Finasteride |
8 |
BLIND RANDOMIZED COMPARATIVE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MESOTHERAPY MINOXIDIL HAIR WITH 0.5% / 2ML VERSUS PLACEBO IN THE TREATMENT OF FEMALE ANDROGENETIC ALOPECIA |
Unknown status |
NCT01655108 |
Phase 3 |
Minoxidil;Saline |
9 |
A Multicentre, Randomized, Double-blind, Parallel-group, Controlled Study, to Assess the Efficacy and Safety of P-3074 Cutaneous Spray, Solution, in the Treatment of Male Pattern Baldness |
Completed |
NCT03004469 |
Phase 3 |
P-3074;Finasteride;P-3074 Vehicle;Finasteride Placebo |
10 |
Evaluating the Efficacy of Topical Herbal Solution on the Treatment of Androgenetic Alopecia and Comparison With Minoxidil 5%: A Double-Blind, Randomized, Clinical Trial Study |
Completed |
NCT03753113 |
Phase 3 |
Topical Herbal Solution;Topical Minoxidil 5% |
11 |
A Prospective Study of Sexual Function in Men Taking Dutasteride for the Treatment of Androgenetic Alopecia |
Completed |
NCT02014584 |
Phase 3 |
Dutasteride;Placebo |
12 |
A Phase 3 Multi-Center Parallel Design Clinical Trial to Compare the Efficacy and Safety of 5% Minoxidil Foam vs. Vehicle in Females for the Treatment of Female Pattern Hair Loss (Androgenetic Alopecia) |
Completed |
NCT01226459 |
Phase 3 |
5% Minoxidil Topical Foam;Vehicle Topical Foam |
13 |
An Randomised, Double-blind, Placebo-controlled, Parallel Group Study to Assess the Efficacy and Safety of Dutasteride 0.5mg Once Daily for 6 Months in the Treatment of Male Subjects With Androgenetic Alopecia (Norwood-Hamilton Classification Type IIIv, IV and V) |
Completed |
NCT00441116 |
Phase 3 |
Dutasteride 0.5mg oral tablets |
14 |
A Phase 3 Multi-Center Parallel Design Clinical Trial to Compare the Efficacy and Safety of 5 % Minoxidil Foam vs. 2 % Minoxidil Solution in Females for the Treatment of Female Pattern Hair Loss - Androgenetic Alopecia (MINALO3004, NCT01145625) |
Completed |
NCT01145625 |
Phase 3 |
5% Minoxidil;2% Minoxidil |
15 |
A Prospective, Randomized, Controlled, Double-Blind Study That Evaluates the Safety and Efficacy of Three Active REVIAN Caps Versus a Non-Active REVIAN Cap (Sham) in Participants With Pattern Hair Loss (Androgenic Alopecia) |
Completed |
NCT04019795 |
Phase 3 |
|
16 |
A Double-Blind, Placebo-Controlled, Multicenter Study To Examine the Effects of Finasteride 1 MG on Serum Prostate-Specific Antigen in Men With Androgenetic Alopecia |
Completed |
NCT00396175 |
Phase 3 |
MK0906, finasteride / Duration of Treatment : 48 Weeks;Comparator : placebo (unspecified) / Duration of Treatment : 48 Weeks |
17 |
Investigator-initiated Single Blind, Two-armed, Randomized Phase 3 Clinical Trial to Compare Efficacy of 5% Minoxidil Topical Foam (5% Mtf) Once Daily Versus 2% Minoxidil Topical Solution (2% Mts) Twice Daily in Application on Females With Slightly to Moderate Androgenetic Alopecia Concerning Hair Volume |
Completed |
NCT00958750 |
Phase 3 |
minoxidil |
18 |
Study ARI114264: A Long-Term Study of the Safety and Efficacy of Dutasteride in the Treatment of Male Subjects With Androgenetic Alopecia |
Completed |
NCT01831791 |
Phase 3 |
Dutasteride 0.5 mg |
19 |
Efficacy of 3% Minoxidil Versus Combined 3% Minoxidil and 0.1% Finasteride for Male Pattern Hair Loss: a Randomized, Double-blinded, Comparative Study |
Completed |
NCT01391156 |
Phase 3 |
3%Minoxidil lotion;3% Minoxidil with 0.1% Finasteride lotion |
20 |
A Study of the Efficacy and Safety of Multiple Doses of Dutasteride Versus Placebo and Finasteride in the Treatment of Male Subjects With Androgenetic Alopecia |
Completed |
NCT01231607 |
Phase 3 |
1mg Finasteride active;0.02mg dutasteride;0.1mg dutasteride;0.5mg dutasteride;Finasteride placebo;Dutasteride placebo |
21 |
A Double-Blind, Randomized, Placebo-Controlled Trial of the Efficacy and Safety of 5 Percent Minoxidil Foam in the Treatment of Androgenetic Alopecia in Males |
Completed |
NCT00151515 |
Phase 3 |
minoxidil |
22 |
Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of 0.15% & 0.25% Concentrations of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia |
Active, not recruiting |
NCT03742518 |
Phase 2, Phase 3 |
Topical SM04554 solution;Topical SM04554 solution;Topical vehicle solution |
23 |
H-36371: Finasteride as a Method of Managing Testosterone-Induced Erythrocytosis |
Withdrawn |
NCT02548117 |
Phase 3 |
Finasteride |
24 |
A Phase 2 Multicenter, Randomized, Placebo-Controlled, Parallel Group Dose-Ranging Study to Evaluate the Safety and Efficacy of Topical NEOSH101 in the Treatment of Androgenetic Alopecia in Men |
Unknown status |
NCT00471510 |
Phase 2 |
tetrapeptide aldehyde proteasome inhibitor (NEOSH101) |
25 |
The Clinical Effects of HSC (Hair Stimulating Complex) on Hair Growth in Androgenetic Alopecia: A Phase I/II Clinical Trial |
Unknown status |
NCT01501617 |
Phase 1, Phase 2 |
|
26 |
A Prospective Multicentric Open Label Randomized Bio-Interventional Phase I/II Pilot Study To Evaluate The Safety And Efficacy Of Autologous Human Platelet Lysate (HPL) For Treatment Of Androgenetic Alopecia (AGA) |
Unknown status |
NCT01643629 |
Phase 1, Phase 2 |
|
27 |
An Efficacy and Safety Pilot Study Comparing 5% Monoxidil Milky Lotion Versus 5% Minoxidil Solution in Treatment of AGA |
Unknown status |
NCT01650272 |
Phase 1, Phase 2 |
5% MInoxidil milky lotion;5% Minoxidil solution |
28 |
Phase 2 Study of Topical AS101 for the Treatment of FAGA (Female Androgenetic Alopecia) in Menopause Women |
Unknown status |
NCT00418249 |
Phase 2 |
AS101 |
29 |
A Multi-center, Randomized, Controlled, Double-blind Study That Evaluates a Low Level Laser Therapy Over-the-counter at Home Device, Theradomeâ„¢ LH80 PRO vs a Sham Device, for Promoting Hair Growth in Males Diagnosed With Androgenetic Alopecia |
Unknown status |
NCT02528552 |
Phase 2 |
|
30 |
A Prospective Multicentric Open Label Randomized Bio-Interventional Phase I/II Pilot Study To Evaluate Safety & Efficacy Of Autologous Human Platelet Lysate For Treatment Of Androgenetic Alopecia In Patients Undergoing Hair Transplant |
Unknown status |
NCT01644422 |
Phase 1, Phase 2 |
|
31 |
A Pilot Study of the Efficacy in Treatment of Female Pattern Hair Loss Using 5% Minoxidil Solution Combinded With Oral Chelated Zinc Supplement |
Unknown status |
NCT01662089 |
Phase 1, Phase 2 |
15 mg Chelate zinc supplement;Placebo drug supplement |
32 |
Safety and Efficacy of Nitric Oxide Gel in Promoting Hair Growth in Male Human Subjects With Androgenetic Alopecia |
Unknown status |
NCT01347957 |
Phase 1, Phase 2 |
|
33 |
A Randomised, Double-blind, Placebo-controlled Phase 2 Trial of FOL-005 to Investigate Efficacy on Hair Growth on Scalp Skin in Healthy Volunteers |
Unknown status |
NCT03467412 |
Phase 2 |
FOL-005;Placebo |
34 |
A Phase 2, Multicenter, Randomized, Double-Blind Study of SM04554 Applied Topically to the Scalp of Male Subjects With Androgenetic Alopecia (AGA) Analyzed by Biopsy of the Scalp Prior To and Post Dosing |
Completed |
NCT02503137 |
Phase 2 |
Topical SM04554 solution;Topical Vehicle solution |
35 |
A Multi-center, Phase 2 Study of Ji Gami(TM) CN That Evaluates the Efficacy and Safety of ex Vivo-cultured, Expanded, Occipital Autologous Dermal and Epidermal Cells, Injected Into the Hair Loss Area of the Scalp of Male and Female Subjects With Alopecia |
Completed |
NCT01669746 |
Phase 2 |
|
36 |
A Multi-center, Phase 2 Study of Ji Gami(TM) CN That Evaluates the Efficacy and Safety of Injections of ex Vivo Expanded Cultured Occipital Autologous Dermal and Epidermal Cells Into the Hair Loss Area of the Scalp of Subjects |
Completed |
NCT01451190 |
Phase 2 |
|
37 |
A Phase 2 Study to Evaluate and Compare the Efficacy of Injections of Cultured Occipital Autologous Dermal and Epidermal Cells vs Dermal Cells, Where Cells Are Expanded ex Vivo From Plucked Scalp, Into the Hair Loss Area of the Scalp of Subjects. |
Completed |
NCT01451177 |
Phase 2 |
|
38 |
A Phase 2 Study to Evaluate and Compare the Efficacy of Injections of ex Vivo Expanded Cultured Occipital Autologous Dermal and Epidermal Cells Into the Hair Loss Area of the Scalp of Subjects |
Completed |
NCT01451151 |
Phase 2 |
|
39 |
A Phase 2 Study to Evaluate and Compare the Efficacy of Injections of ex Vivo Expanded Cultured Occipital Autologous Dermal and Epidermal Cells vs Dermal Cells Into the Hair Loss Area of the Scalp of Subjects |
Completed |
NCT01451138 |
Phase 2 |
|
40 |
A Phase 2 Study to Evaluate and Compare the Efficacy of Injections of Ex Vivo Expanded Cultured Occipital Autologous Dermal and Epidermal Cells vs. Dermal Cells Into the Hair Loss Area of the Scalp of Subjects and Synergy With Application of Topical Minoxidil |
Completed |
NCT01451125 |
Phase 2 |
|
41 |
A Phase 2 Study to Evaluate and Compare the Efficacy of Injections of Ex Vivo Expanded Cultured Occipital Autologous Dermal and Epidermal Cells vs. Dermal Cells Into the Hair Loss Area of the Scalp of Subjects |
Completed |
NCT01451112 |
Phase 2 |
|
42 |
A Phase 2 Randomized Study to Evaluate and Compare the Efficacy of Injections of Ex Vivo Expanded Cultured Occipital Autologous Dermal Cells Into the Balding Scalp of Subjects With Hair Loss |
Completed |
NCT01451099 |
Phase 2 |
|
43 |
A Phase 2 Randomized Study to Evaluate and Compare the Efficacy of a 1 Time Injection vs. Repeat Injections of ex Vivo Expanded Cultured Autologous Occipital Dermal and Epidermal Cells (Same Day as Cell Culture Harvest) Into the Balding Scalp of Subjects With Hair Loss |
Completed |
NCT01451073 |
Phase 2 |
|
44 |
A Phase 2 Randomized Study to Evaluate and Compare the Efficacy of Injections of ex Vivo Expanded Cultured Occipital Autologous Dermal and Epidermal Cells vs. Dermal Cells Into the Balding Scalp of Subjects With Hair Loss |
Completed |
NCT01451047 |
Phase 2 |
|
45 |
A Phase 2 Randomized Study to Evaluate and Compare the Efficacy of a 1 Time Injection vs. Repeat Injections of ex Vivo Expanded Cultured Autologous Occipital Dermal and Epidermal Cells (Day After Cell Culture Harvest) Into the Balding Scalp of Subjects With Hair Loss |
Completed |
NCT01451021 |
Phase 2 |
|
46 |
A Prospective, Single Center, Open Label, Proof of Principle Study to Assess the Efficacy and Safety of 150 Units of Botulinum Toxin-A Intra-Muscular Injection in the Prevention of Hair Loss in Men With Androgenetic Alopecia |
Completed |
NCT00965640 |
Phase 2 |
Botulinum Toxin - A injections |
47 |
A Phase 2 Multicenter, Randomized, Placebo- and Comparator-Controlled, Double-Blind Parallel Group Study to Evaluate the Safety and Efficacy of Topical NEOSH101 in the Treatment of Androgenetic Alopecia in Men |
Completed |
NCT00418730 |
Phase 2 |
tetrapeptide aldehyde proteasome inhibitor (NEOSH101) |
48 |
A Phase 2, Multicenter, Randomized, Double-Blind, Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Solution 5%, Minoxidil Solution 5%, and Vehicle Solution, Applied Twice-daily for 26 Weeks in Males With Androgenetic Alopecia (AGA) |
Completed |
NCT02279823 |
Phase 2 |
CB-03-01 solution;Minoxidil Solution 5%;Placebo solution |
49 |
A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle- Controlled Study of the Safety, Tolerability, and Efficacy of 0.15% and 0.25% Concentrations of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA) |
Completed |
NCT02275351 |
Phase 2 |
SM04554;Vehicle |
50 |
Randomized, Single-centre, Double-blind, Placebo-controlled, Phase I / IIa Study to Evaluate the Safety and Efficacy of Human Autologous Hair Follicle Dermal Sheath Cup Cells (DSCC) in Women and Men With Androgenetic Alopecia. |
Completed |
NCT01286649 |
Phase 1, Phase 2 |
|
Cell-based therapeutics:
Data from LifeMap, the Embryonic Development and Stem Cells Database
Stem-cell-based therapeutic approaches for Alopecia, Androgenetic, 1:
Embryonic/Adult Cultured Cells Related to Alopecia, Androgenetic, 1:
|